C Warren Olanow Selected Research

Parkinson Disease (Parkinson's Disease)

05/2008	Lewy body-like pathology in long-term embryonic nigral transplants in Parkinson's disease.
05/2008	Safety and tolerability of intraputaminal delivery of CERE-120 (adeno-associated virus serotype 2-neurturin) to patients with idiopathic Parkinson's disease: an open-label, phase I trial.
01/2008	Levodopa therapy for Parkinson's disease: challenges and future prospects.
01/2008	Levodopa/dopamine replacement strategies in Parkinson's disease--future directions.
10/2007	Leucine-rich repeat kinase 2 (LRRK2)/PARK8 possesses GTPase activity that is altered in familial Parkinson's disease R1441C/G mutants.
01/2007	Sarizotan as a treatment for dyskinesias in Parkinson's disease: a double-blind placebo-controlled trial.
12/2006	TCH346 as a neuroprotective drug in Parkinson's disease: a double-blind, randomised, controlled trial.
11/2006	Ubiquitin-proteasome system and Parkinson's disease.
08/2006	Proteasome inhibitor-induced model of Parkinson's disease.
08/2006	Continuous dopamine-receptor treatment of Parkinson's disease: scientific rationale and clinical implications.
06/2005	Intermittent vs continuous levodopa administration in patients with advanced Parkinson disease: a clinical and pharmacokinetic study.
12/2004	Levodopa and the progression of Parkinson's disease.
10/2004	Neuroprotective agents in Parkinson's disease: clinical evidence and caveats.
09/2004	Levodopa in the treatment of Parkinson's disease: current controversies.
08/2004	Double-blind, randomized, controlled trial of rasagiline as monotherapy in early Parkinson's disease patients.
07/2004	Systemic exposure to proteasome inhibitors causes a progressive model of Parkinson's disease.
03/2004	Multicenter, open-label, trial of sarizotan in Parkinson disease patients with levodopa-induced dyskinesias (the SPLENDID Study).
01/2004	COMT inhibitors in Parkinson's disease: can they prevent and/or reverse levodopa-induced motor complications?
09/2003	A double-blind controlled trial of bilateral fetal nigral transplantation in Parkinson's disease.
07/2003	Assessment of sleepiness and unintended sleep in Parkinson's disease patients taking dopamine agonists.
02/2003	Dietary vitamin E and Parkinson's disease: something to chew on.
01/2003	Rationale for the use of dopamine agonists as neuroprotective agents in Parkinson's disease.
09/2002	Prospective randomized trial of lisuride infusion versus oral levodopa in patients with Parkinson's disease.
07/2002	Selective loss of 20S proteasome alpha-subunits in the substantia nigra pars compacta in Parkinson's disease.
05/2002	Impact of sustained deprenyl (selegiline) in levodopa-treated Parkinson's disease: a randomized placebo-controlled extension of the deprenyl and tocopherol antioxidative therapy of parkinsonism trial.
02/2002	The role of dopamine agonists in the treatment of early Parkinson's disease.

Articles by Research Topic

Disease

26	Parkinson Disease (Parkinson's Disease) 05/2008 - 02/2002
2	Movement Disorders (Movement Disorder) 05/2008 - 01/2006
2	Parkinsonian Disorders (Parkinsonism) 08/2007 - 05/2002
2	Dyskinesias (Dyskinesia) 01/2007 - 03/2004

Drug/Important Bio-Agent (IBA)

9	Levodopa (L Dopa)FDA LinkGeneric 01/2008 - 05/2002
4	Proteasome Endopeptidase Complex (Proteasome)IBA 11/2006 - 07/2002
3	Dopamine Agonists (Dopamine Agonist)IBA 07/2003 - 02/2002
2	sarizotanIBA 01/2007 - 03/2004
2	Neuroprotective AgentsIBA 10/2004 - 01/2003
1	NeurturinIBA 05/2008
1	Dopamine (Intropin)FDA LinkGeneric 01/2008
1	Phosphotransferases (Kinase)IBA 10/2007
1	Leucine (L-Leucine)FDA Link 10/2007
1	GTP Phosphohydrolases (GTPases)IBA 10/2007
1	ManganeseIBA 08/2007
1	dibenzo(b,f)oxepin- 10- ylmethyl- methyl- prop- 2- ynyl- amine (TCH346)IBA 12/2006
1	UbiquitinIBA 11/2006
1	Dopamine Receptors (Dopamine Receptor)IBA 08/2006
1	Direction compoundIBA 01/2006
1	rasagiline (Azilect)FDA Link 08/2004
1	Vitamin E FDA Link 02/2003
1	LisurideIBA 09/2002
1	Selegiline (E250)FDA LinkGeneric 05/2002

Therapy/Procedure

1	Home Nursing (Nursing, Home) 05/2008
1	Transplants (Transplant) 05/2008
1	Transplantation (Transplant Recipients) 09/2003